TTR protection in AD is probably dependent on its stability, and although genetic tests performed so far did not reveal mutations in the TTR gene of AD patients [46], destabilization of the protein may result from other events, such as metal ions concentration and interaction with other proteins. This evidence concerns the gene TTR and Alzheimer disease.